España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Passage Bio
PASG
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.861200
-0.04
-4.30%
Last update: Jul 19, 5:41 PM
15 minutes delayed
Get Report
Comment
Passage Bio (PASG) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Passage Bio (NASDAQ:PASG) Stock
Passage Bio Stock (NASDAQ: PASG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 16, 2024
Passage Bio Receives Positive Feedback From F...
Benzinga Newsdesk
Wednesday, May 15, 2024
Canaccord Genuity Maintains Buy on Passage Bi...
Benzinga Newsdesk
Tuesday, March 05, 2024
Canaccord Genuity Reiterates Buy on Passage B...
Benzinga Newsdesk
Monday, March 04, 2024
Passage Bio Tapped Kathleen Borthwick as CFO,...
Benzinga Newsdesk
Friday, January 26, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Wednesday, January 17, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, December 21, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, December 20, 2023
Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Passage Bio Announced Initial Safety And Biom...
Benzinga Newsdesk
Tuesday, November 14, 2023
Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
Lisa Levin
Raymond James Maintains Outperform on Passage...
Benzinga Newsdesk
Monday, November 13, 2023
Passage Bio Q3 EPS $(0.49) Misses $(0.46) Est...
Benzinga Newsdesk
Recap: Passage Bio Q3 Earnings
Benzinga Insights
Friday, November 03, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Tuesday, August 22, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Tuesday, August 08, 2023
Chardan Capital Maintains Buy on Passage Bio,...
Benzinga Newsdesk
Monday, August 07, 2023
Passage Bio Announces Interim Data From First...
Benzinga Newsdesk
Passage Bio Q2 EPS $(0.44) Beats $(0.48) Esti...
Benzinga Newsdesk
Thursday, August 03, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, August 01, 2023
Director at Passage Bio Acquires Company Stock Options Worth 48,000 Shares
Benzinga Insights
Thursday, July 20, 2023
Passage Bio Said Will Decrease Operating Expe...
Charles Gross
Passage Bio Said On July 19, Announced Organizational Redesign To Further Extend Its Cash Runway; Said Simona King To Resign As CFO, Kathleen Borthwick Named Interim CFO
Charles Gross
Friday, June 30, 2023
Passage Bio 10% Owner Trades Company's Stock
Benzinga Insights
Passage Bio And 2 Other Penny Stocks Insiders Are Aggressively Buying
Lisa Levin
Thursday, June 15, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, June 14, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Friday, May 12, 2023
Raymond James Maintains Outperform on Passage...
Benzinga Newsdesk
Thursday, May 11, 2023
Recap: Passage Bio Q1 Earnings
Benzinga Insights
Passage Bio Q1 EPS $(0.63) Misses $(0.49) Est...
Benzinga Newsdesk
Monday, April 03, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Monday, March 27, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, March 24, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, March 06, 2023
Passage Bio Q4 EPS $(0.50) Beats $(0.52) Esti...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2023
Benzinga Insights
Friday, March 03, 2023
Passage Bio's Earnings: A Preview
Benzinga Insights
Friday, February 24, 2023
Passage Bio Announced Updated Clinical Data F...
Benzinga Newsdesk
Thursday, December 15, 2022
Expert Ratings for Passage Bio
Benzinga Insights
Chardan Capital Maintains Buy on Passage Bio,...
Benzinga Newsdesk
Wednesday, December 14, 2022
Passage Bio Stock Jumps After Gene Therapy Study In Lysosomal Storage Disorder
Vandana Singh
Passage Bio shares are trading higher after t...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Passage Bio Announces Interim Data From First Six Patients With GM1 Gangliosidosis In Imagine-1 Study Showing 'low and high dose of PBGM01 were well tolerated and had a favorable safety profile'
Bill Haddad
Wednesday, December 07, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch